Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship.
Lawrentschuk
Nathan
N
Department of Surgery, University of Melbourne, Australia. nathan.lawrentschuk@ludwig.edu.au
Davis
Ian D
ID
Bolton
Damien M
DM
Scott
Andrew M
AM
D000085:Acetates; D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D002794:Choline; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D009367:Neoplasm Staging / Q000379:methods; D009593:Nitroimidazoles; D049268:Positron-Emission Tomography / Q000379:methods*; D016719:Radioimmunodetection / Q000379:methods*; D016499:Radioimmunotherapy / Q000379:methods*; D019275:Radiopharmaceuticals
D000085:Acetates; D009593:Nitroimidazoles; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D002794:Choline